Possible relation between viruses and oromaxillofacial tumors. I. Demonstration of herpes antigens and anti-herpes antibodies
Stoian, M.; Suru, M.; Zaharia, O.; Hozoc, M.; Nastac, E.; Fleshler, B.A.
Virologie 38(1): 25-34
1987
ISSN/ISBN: 0253-181X PMID: 3033877 Document Number: 4480
Herpes virus type 1 and 2 antigens were detected in cells originating from malignant tumors with oromaxillofacial localization. A higher incidence of type 1 antigens was noted, as compared to the type 2. Investigated antigens were detected more frequently in the tumors of ectodermal origin. Antiherpesvirus FC antibodies were found in 74.5% of the tumor bearing subjects, but only in 22.3% of the controls.
Document emailed within 1 workday
Related Documents
Trlifajová, J.; Sourek, J.; Ryba, M. 1971: Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction Acta Virologica 15(4): 293-300Scheffer, A.J.; Koedijk, D.G.; Abee, T.; Osterhaus, A.D. 1984: Monoclonal antibodies against herpes simplex viruses Developments in Biological Standardization 57: 269-274
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326
Slomka, M.J. 1996: Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus Communicable Disease Report. Cdr Review 6(3): R41-R45
Kasparov, A.A.; Voĭtsekhovskaia, A.A. 1982: Anti-relapse therapy of ocular herpes patients with increased sensitivity to herpes simplex virus Vestnik Oftalmologii 5: 42-43
Andreansky, S.; Soroceanu, L.; Flotte, E.R.; Chou, J.; Markert, J.M.; Gillespie, G.Y.; Roizman, B.; Whitley, R.J. 1997: Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors Cancer Research 57(8): 1502-1509
Glorioso, J.C.; Smith, J.W. 1977: Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens Journal of Immunology 118(1): 114-121
Puthavathana, P.; Kanyok, R.; Horthongkham, N.; Roongpisuthipong, A. 1998: Prevalence of herpes simplex virus infection in patients suspected of genital herpes; and virus typing by type specific fluorescent monoclonal antibodies Journal of the Medical Association of Thailand 81(4): 260-264
Cokić-Damjanović, J. 1992: Antibody titer levels and the presence of herpes simplex virus antibodies in the serum in relation to gender Medicinski Pregled 45(11-12): 441-443
Schlipköter, H.W.; Stiller-Winkler, R.; Idel, H.; Knopp, J. 1981: Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. 1. Abt. Originale B Hygiene 174(1-2): 105-114
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
Herdewijn, P. 1995: Structure-activity relation study of anti-herpes associations with a 2'-deoxyuridine basic structure Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 57(6): 601-615
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Kapoor, A.K.; Ling, N.R.; Bazeley, M. 1977: Lymphocyte stimulation by herpes simplex virus (HSV) antigens. 1. Culture conditions, cell fractionation and presentation of HSV antigens Cytobios 20(79-80): 151-162
Chida, K.; Takase, S. 2000: Serological diagnostic trial of the causative virus of Bell's palsy by anti-herpes virus antibodies in the paired sera Rinsho Shinkeigaku 40(8): 791-796
Voigt, H. 1975: The herpes viruses Zeitschrift für Allgemeinmedizin 51(29): 1323-1325
Rafferty, K.A. 1973: Herpes viruses and cancer Scientific American 229(4): 26-33
Yamauchi, Y. 2006: Molecular chaperones and herpes simplex viruses Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 3): 163-166
Kubo, T.; Rai, S.K.; Nakanishi, M.; Yamano, T. 1991: Seroepidemiological study of herpes viruses in Nepal Southeast Asian Journal of Tropical Medicine and Public Health 22(3): 323-325